HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Glucose metabolism and hyperglycemia.

Abstract
Islet dysfunction and peripheral insulin resistance are both present in type 2 diabetes and are both necessary for the development of hyperglycemia. In both type 1 and type 2 diabetes, large, prospective clinical studies have shown a strong relation between time-averaged mean values of glycemia, measured as glycated hemoglobin (HbA1c), and vascular diabetic complications. These studies are the basis for the American Diabetes Association's current recommended treatment goal that HbA1c should be <7%. The measurement of the HbA1c concentration is considered the gold standard for assessing long-term glycemia; however, it does not reveal any information on the extent or frequency of blood glucose excursions, but provides an overall mean value only. Postprandial hyperglycemia occurs frequently in patients with diabetes receiving active treatment and can occur even when metabolic control is apparently good. Interventional studies indicate that reducing postmeal glucose excursions is as important as controlling fasting plasma glucose in persons with diabetes and impaired glucose tolerance. Evidence exists for a causal relation between postmeal glucose increases and microvascular and macrovascular outcomes; therefore, it is not surprising that treatment with different compounds that have specific effects on postprandial glucose regulation is accompanied by a significant improvement of many pathways supposed to be involved in diabetic complications, including oxidative stress, endothelial dysfunction, inflammation, and nuclear factor-kappaB activation. The goal of therapy should be to achieve glycemic status as near to normal as safely possible in all 3 components of glycemic control: HbA1c, fasting glucose, and postmeal glucose peak.
AuthorsDario Giugliano, Antonio Ceriello, Katherine Esposito
JournalThe American journal of clinical nutrition (Am J Clin Nutr) Vol. 87 Issue 1 Pg. 217S-222S (Jan 2008) ISSN: 0002-9165 [Print] United States
PMID18175761 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Blood Glucose
  • Glycated Hemoglobin A
Topics
  • Area Under Curve
  • Blood Glucose (metabolism)
  • Diabetes Complications
  • Diabetes Mellitus, Type 2 (complications, metabolism, prevention & control)
  • Fasting (blood)
  • Glycated Hemoglobin (analysis, metabolism)
  • Glycemic Index
  • Humans
  • Hyperglycemia (complications, metabolism, prevention & control)
  • Life Style
  • Postprandial Period
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: